Paricalcitol: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

12 April 2024

  • curprev 23:1423:14, 12 April 2024 Fire talk contribs 8,926 bytes +207 Marked this version for translation
  • curprev 23:1323:13, 12 April 2024 Fire talk contribs 8,719 bytes +39 No edit summary
  • curprev 23:0823:08, 12 April 2024 Fire talk contribs 8,680 bytes −102 No edit summary
  • curprev 23:0823:08, 12 April 2024 Fire talk contribs 8,782 bytes +8,782 Created page with "{{short description|Chemical compound}} {{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 445909355 | IUPAC_name = (1''R'',3''R'',7''E'',17β)-17-[(1''R'',2''E'',4''S'')-5-hydroxy-1,4,5-trimethylhex-2-en-1-yl]-9,10-secoestra-5,7-diene-1,3-diol | image = Paricalcitol.svg | width = 200px | image2 = Paricalcitol3Dan.gif | width2 = 200px <!--Clinical data--> | tradename = Zemplar | Drugs.com = {{drugs.com|monograph|paricalcitol}} | MedlinePlus..."